JP2016517418A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016517418A5 JP2016517418A5 JP2016502103A JP2016502103A JP2016517418A5 JP 2016517418 A5 JP2016517418 A5 JP 2016517418A5 JP 2016502103 A JP2016502103 A JP 2016502103A JP 2016502103 A JP2016502103 A JP 2016502103A JP 2016517418 A5 JP2016517418 A5 JP 2016517418A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- cyclodextrin
- excipients
- particles
- lactide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361786035P | 2013-03-14 | 2013-03-14 | |
| US61/786,035 | 2013-03-14 | ||
| PCT/US2014/026320 WO2014151725A1 (en) | 2013-03-14 | 2014-03-13 | Composition of a sustained-release delivery and method of stabilizing proteins during fabrication process |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019217753A Division JP2020029466A (ja) | 2013-03-14 | 2019-12-02 | タンパク質の徐放性送達の組成物及び製造プロセス中のタンパク質の安定化方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016517418A JP2016517418A (ja) | 2016-06-16 |
| JP2016517418A5 true JP2016517418A5 (https=) | 2018-08-02 |
| JP6649246B2 JP6649246B2 (ja) | 2020-02-19 |
Family
ID=50483567
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502103A Expired - Fee Related JP6649246B2 (ja) | 2013-03-14 | 2014-03-13 | タンパク質の徐放性送達の組成物及び製造プロセス中のタンパク質の安定化方法 |
| JP2019217753A Pending JP2020029466A (ja) | 2013-03-14 | 2019-12-02 | タンパク質の徐放性送達の組成物及び製造プロセス中のタンパク質の安定化方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019217753A Pending JP2020029466A (ja) | 2013-03-14 | 2019-12-02 | タンパク質の徐放性送達の組成物及び製造プロセス中のタンパク質の安定化方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20140274873A1 (https=) |
| EP (2) | EP2968574A1 (https=) |
| JP (2) | JP6649246B2 (https=) |
| KR (1) | KR20150128857A (https=) |
| CN (1) | CN105188759A (https=) |
| AU (2) | AU2014236938B2 (https=) |
| BR (1) | BR112015021000A2 (https=) |
| CA (1) | CA2902547A1 (https=) |
| RU (1) | RU2720412C2 (https=) |
| WO (1) | WO2014151725A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106076214B (zh) * | 2016-07-15 | 2019-12-17 | 沈阳化工大学 | 一种具有核壳结构的海藻酸钙微球制备方法 |
| GB201906835D0 (en) * | 2019-05-15 | 2019-06-26 | Ucb Biopharma Sprl | Dry microparticles |
| WO2022163966A1 (ko) * | 2021-01-29 | 2022-08-04 | 주식회사 티온랩테라퓨틱스 | 초기 방출 제어된 데포 조성물 및 이의 제조방법 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4777043A (en) * | 1985-12-17 | 1988-10-11 | Genentech, Inc. | Stabilized human tissue plasminogen activator compositions |
| US5997856A (en) * | 1988-10-05 | 1999-12-07 | Chiron Corporation | Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
| KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US6448077B1 (en) | 1994-02-10 | 2002-09-10 | Imclone Systems, Inc. | Chimeric and humanized monoclonal antibodies specific to VEGF receptors |
| ATE201983T1 (de) * | 1995-03-10 | 2001-06-15 | Roche Diagnostics Gmbh | Polypeptid-enthaltende pharmazeutische darreichungsformen in form von mikropartikeln und verfahren zu deren herstellung |
| GB9514285D0 (en) * | 1995-07-13 | 1995-09-13 | Univ Nottingham | Polymeric lamellar substrate particles for drug delivery |
| US5665428A (en) * | 1995-10-25 | 1997-09-09 | Macromed, Inc. | Preparation of peptide containing biodegradable microspheres by melt process |
| US6884879B1 (en) | 1997-04-07 | 2005-04-26 | Genentech, Inc. | Anti-VEGF antibodies |
| JP4360758B2 (ja) * | 1999-04-08 | 2009-11-11 | ジェネンテック・インコーポレーテッド | 逆の電荷のポリペプチド類をベースにした組成物 |
| DE60127175T2 (de) * | 2000-12-21 | 2007-11-08 | Nektar Therapeutics, San Carlos | Lagerstabile pulverzusammensetzungen mit interleukin-4 rezeptor |
| EP1436329A4 (en) | 2001-09-20 | 2005-04-27 | Alexion Pharma Inc | ANTI-PDGF ANTIBODIES AND METHODS FOR PRODUCING FOCUSED ANTIBODIES |
| US7265084B2 (en) * | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| US9415102B2 (en) * | 2002-09-06 | 2016-08-16 | Alexion Pharmaceuticals, Inc. | High concentration formulations of anti-C5 antibodies |
| KR100466637B1 (ko) * | 2003-06-26 | 2005-01-13 | 주식회사 펩트론 | 서방성 미립구의 혼합 제형을 연속한 단일 공정으로제조하는 방법 |
| US20060182783A1 (en) * | 2004-04-30 | 2006-08-17 | Allergan, Inc. | Sustained release intraocular drug delivery systems |
| US7993634B2 (en) * | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
| US8591885B2 (en) * | 2004-04-30 | 2013-11-26 | Allergan, Inc. | Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems |
| WO2005110374A1 (en) * | 2004-04-30 | 2005-11-24 | Allergan, Inc. | Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
| CA2593112A1 (en) * | 2005-01-21 | 2006-07-27 | Alza Corporation | Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion |
| MX2007013213A (es) * | 2005-04-25 | 2007-12-12 | Amgen Inc | Composiciones de liberacion prolongada de peptidos biodegradables que contienen porogenos. |
| JP5074750B2 (ja) * | 2005-12-07 | 2012-11-14 | 一般財団法人化学及血清療法研究所 | シクロデキストリン類を含有する液状フィブリノゲン製剤 |
| US8642067B2 (en) * | 2007-04-02 | 2014-02-04 | Allergen, Inc. | Methods and compositions for intraocular administration to treat ocular conditions |
| WO2009031011A2 (en) * | 2007-09-05 | 2009-03-12 | Pfizer Limited | Xinafoate salt of n4-(2, 2-difluoro-4h-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-n2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine |
| WO2009099132A1 (ja) * | 2008-02-05 | 2009-08-13 | Kyowa Hakko Bio Co., Ltd. | グルタチオンの保存安定性向上方法 |
| EP3785735A1 (en) * | 2008-11-03 | 2021-03-03 | Molecular Partners AG | Binding proteins inhibiting the vegf-a receptor interaction |
| CA2776472A1 (en) | 2009-10-01 | 2011-04-07 | Evonik Degussa Corporation | Microparticle compositions and methods for treating age-related macular degeneration |
| US9668915B2 (en) * | 2010-11-24 | 2017-06-06 | Dose Medical Corporation | Drug eluting ocular implant |
-
2014
- 2014-03-13 AU AU2014236938A patent/AU2014236938B2/en not_active Ceased
- 2014-03-13 BR BR112015021000A patent/BR112015021000A2/pt not_active IP Right Cessation
- 2014-03-13 EP EP14717337.1A patent/EP2968574A1/en not_active Withdrawn
- 2014-03-13 CA CA2902547A patent/CA2902547A1/en not_active Abandoned
- 2014-03-13 US US14/209,683 patent/US20140274873A1/en not_active Abandoned
- 2014-03-13 EP EP20167724.2A patent/EP3693021A1/en not_active Withdrawn
- 2014-03-13 RU RU2015135147A patent/RU2720412C2/ru active
- 2014-03-13 JP JP2016502103A patent/JP6649246B2/ja not_active Expired - Fee Related
- 2014-03-13 KR KR1020157027832A patent/KR20150128857A/ko not_active Ceased
- 2014-03-13 CN CN201480015377.2A patent/CN105188759A/zh active Pending
- 2014-03-13 WO PCT/US2014/026320 patent/WO2014151725A1/en not_active Ceased
-
2019
- 2019-03-19 AU AU2019201884A patent/AU2019201884B2/en not_active Ceased
- 2019-12-02 JP JP2019217753A patent/JP2020029466A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Raja et al. | Polymeric nanomaterials: methods of preparation and characterization | |
| Lee et al. | PLA micro-and nano-particles | |
| Zafar et al. | Polysaccharide based bionanocomposites, properties and applications: A review | |
| EA201390600A1 (ru) | Терапевтические наночастицы с сополимерами с большим молекулярным весом | |
| JP2012031414A5 (https=) | ||
| JP2016501292A5 (https=) | ||
| JP2015154957A5 (https=) | ||
| JP2017511322A5 (https=) | ||
| JP2019507229A5 (https=) | ||
| AR086660A1 (es) | Composicion para el tratamiento de diabetes que comprende un conjugado de insulina de accion prolongada y conjugado de un peptido insulinotropico de accion prolongada | |
| MX351986B (es) | Composiciones polimericas bioabsorbibles, metodos de procesamiento y dispositivos medicos de estas. | |
| JP2013519636A5 (https=) | ||
| AR080093A1 (es) | Pelicula soluble en agua mejorada con una mezcla de polimeros de pvoh y empaques elaborados de esta | |
| AR103981A1 (es) | Métodos y composiciones particularmente para el tratamiento del trastorno por déficit de atención | |
| JP2016517418A5 (https=) | ||
| CY1125511T1 (el) | Συνθεση που περιλαμβανει χιτοζανη και ενα μυκητοκτονο | |
| MX2016006913A (es) | Composiciones de mezclas polimericas absorbibles con velocidades de absorcion controlables de manera precisa, metodos de procesamiento y dispositivos medicos dimensionalmente estables elaborados a partir de estas. | |
| EA200900685A1 (ru) | Самособирающиеся амфифильные полимеры в качестве противовирусных средств | |
| ATE549012T1 (de) | Pharmazeutische zusammensetzung mit s- nitrosoglutathion und polysaccharid | |
| MX2017001925A (es) | Copolimeros de etileno producidos con un catalizador de un solo sitio. | |
| WO2019055996A8 (en) | Polymer nanodiscs for biotechnology and medical applications | |
| ES2570655T3 (es) | Composición para preparar un material polimérico biodegradable nanoestructurado, el material obtenido y sus usos | |
| EA201891781A1 (ru) | Химически инертный термоплавкий клей с сополимером на основе лактида | |
| JP2018510792A5 (https=) | ||
| RU2015135147A (ru) | Композиции доставки с замедленным высвобождением и способ стабилизации белков в процессе изготовления |